Who is using CellRaft Technology?
A Few Ways CellRaft® Technology is Being Used in Customer Labs
Scientific Poster: Accelerating Generation of Single Cell Clones
Poster: Leveraging a CRISPR-based LAPSE Workflow to Guide Drug Targeting Strategies
Case Study: Identification of a Rare Double Positive Clone
Journal Article: Detection of unintended on-target effects in CRISPR genome editing by DNA donors carrying diagnostic substitutions
Journal Article: A rare human centenarian variant of SIRT6 enhances genome stability and interaction with Lamin A
Journal Article: Pooled image-base screening of mitochondria with microraft isolation distinguishes pathogenic mitofusin 2 mutations
Journal Article: PDS5A and PDS5B differentially affect gene expression without altering cohesin localization across the genome
Journal Article: RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells
Customer's Quotes
Rating 5.0 / review on SelectScience: "I can recommend it to anyone who wants to pick single cells or clone... It is user-friendly."
Rating Extremely Satisfied (5 Stars): “The system is great for difficult-to-clone cell lines and has powerful imaging technology to help with our cell engineering assays.”
“We recommend the CellRaft Technology for our colleagues struggling with single cell isolation. Even with help from FACS, although single cell clones could be obtained, from our experiences, CellRaft not only speeds up this process by providing many more clones but more importantly, the unique monitoring process provided by CellRaft supplies additional information for every single clone with a higher quality of clones.”
“We can now easily identify thousands of single organoids with various morphologies (size, shape, complexity) and isolate hundreds in less than an hour. We also use the CellRaft AIR System for cloning of transgenic or CRISPR-edited human intestinal stem cells. Prior to the air system, the efficiency of isolating clonal lines was very inefficient because of the low throughput. Now we can isolate hundreds or thousands of clonal organoids in an unprecedented short amount of time compared to before.”
